Petlife Pharmaceuticals, Inc. (PTLF)

Petlife Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Feb 28, 2018	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013
Cost of Revenue	0.02	0.02	-	0.22	0.06	-
Gross Profit	-0.02	-0.02	-	-0.22	-0.06	-
Selling, General & Admin	1.17	1.27	2.95	1.71	1.38	0
Research & Development	-	-	-	-	0.07	-
Operating Expenses	2.39	22.39	3.69	1.71	1.45	0
Operating Income	-2.41	-22.4	-3.69	-1.93	-1.51	-0
Interest Expense	-0.49	-0.38	-	-	-	-
Other Non Operating Income (Expenses)	-0.24	-0.01	-	-	-	-
EBT Excluding Unusual Items	-3.14	-22.79	-3.69	-1.93	-1.51	-0
Asset Writedown	-0.25	-0.25	-	-	-	-
Other Unusual Items	-0.32	-0.21	-	-	-	-
Pretax Income	-3.71	-23.26	-3.69	-1.93	-1.51	-0
Net Income	-3.71	-23.26	-3.69	-1.93	-1.51	-0
Net Income to Common	-3.71	-23.26	-3.69	-1.93	-1.51	-0
Shares Outstanding (Basic)	89	69	9	11	8	8
Shares Outstanding (Diluted)	89	69	9	11	8	8
Shares Change (YoY)	323.01%	654.09%	-20.38%	42.84%	5.59%	-
EPS (Basic)	-0.04	-0.34	-0.40	-0.17	-0.19	-
EPS (Diluted)	-0.04	-0.34	-0.40	-0.17	-0.19	-
Free Cash Flow	-0.26	-0.32	-0.15	-0.02	-0.27	-
Free Cash Flow Per Share	-0.00	-0.01	-0.02	-0.00	-0.03	-
EBIT	-2.41	-22.4	-3.69	-1.93	-1.51	-0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.